Literature DB >> 6736686

Evaluation of an automated image analysis system for counting human tumor colonies.

S E Salmon, L Young, J Lebowitz, S Thomson, J Einsphar, T Tong, T E Moon.   

Abstract

The Omnicon FAS II image analysis system was applied to counting tumor colonies grown in a soft agar human tumor clonogenic assay with a detailed protocol designed to assess the instrument's sensitivity, specificity, precision, and accuracy. Comparisons of technician and instrument counts were done on a blinded basis. Sensitivity studies (which used metal microspheres) yielded a correlation coefficient (r) of 0.999 between technicians and the counter. A field-by-field analysis of the instrument's specificity for identifying individual objects correctly as tumor colonies rather than artifacts (as identified by the technician) was excellent (r = 0.95). In the precision studies (determined with repeated automated counting of the same samples for five days), the median coefficient of variation was less than 7%. Accuracy was evaluated on cultures of fresh biopsies from 30 human cancers obtained for drug sensitivity testing as well as on a series of tumor cell lines. The correlation between the mean number of colonies counted by the technicians and by the colony counter was greater than 0.91. Similar comparisons of mean percent survival of tumor colony-forming cells after drug exposure between technician and machine were also quite acceptable (r = 0.85). We conclude that the colony counter provided sufficient reliability to be applied to counting human tumor colonies grown in vitro. In addition, the colony counter performed the Petri dish counts ten times faster than experienced technicians and without associated operator fatigue.

Entities:  

Mesh:

Year:  1984        PMID: 6736686     DOI: 10.1002/stem.5530020301

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  8 in total

1.  In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines.

Authors:  M J Xu; D S Alberts; R Liu; A Leibovitz; Y Liu
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor.

Authors:  R T Dorr; K Dvorakova; K Snead; D S Alberts; S E Salmon; G R Pettit
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

3.  Comparative in vitro activity of 4'-deoxy-4'-iododoxorubicin and other anthracyclines in the human tumor clonogenic assay.

Authors:  J E Schwartz; S E Salmon
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

4.  Antitumor activity of new anthracycline analogues in combination with interferon alfa.

Authors:  M E Berens; T Saito; C E Welander; E J Modest
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells.

Authors:  R T Dorr; J D Liddil; M J Soble
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

6.  Neoplastic cell inhibition with new ether lipid analogs.

Authors:  A Noseda; M E Berens; C Piantadosi; E J Modest
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

7.  Counting colonies of clonogenic assays by using densitometric software.

Authors:  Maximilian Niyazi; Ismat Niyazi; Claus Belka
Journal:  Radiat Oncol       Date:  2007-01-09       Impact factor: 3.481

8.  Radiation survival of murine and human melanoma cells utilizing two assay systems: monolayer and soft agar.

Authors:  K H Yohem; D J Slymen; M D Bregman; F L Meyskens
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.